This work showcases the utility of KIM-1 and NGAL for early risk assessment of kidney injury of drug candidates, in addition to the utility of a humanized liver mouse models to assess safety concerns and predict human metabolites as an alternative to standard preclinical toxicology species such as non-human primates.
Click here to download this scientific poster!
Interested in learning more about our DMPK services? Click here for an overview of our services and access to frequently asked questions.
